Krka Banned From Selling Telmisartan in Poland
Novo Mesto, 29 December - The District Court in Warsaw has issued a patent infringement injunction banning the Polish subsidiary of pharma company Krka from selling Tolura, a cardiovascular protection drug containing the active substance telmisartan.
The rest of this news item is available to subscribers.
The news item consists of 392 characters (without spaces) or 76 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.